AAVAS Financiers Ltd

BSE: 541988

107

total announcements

541988.BO · 15 min delayed

BSECompany UpdateFundraise21 Jul 2026

AAVAS Financiers Ltd

Outcome of Executive Committee meeting of the Board of Directors held on July 21, 2026

AAVAS Financiers Ltd has announced the outcome of its Executive Committee meeting, where it approved the issuance of up to 20,000 senior, secured, rated, listed, transferable, redeemable non-convertible debentures (NCDs) with a face value of Rs. 1,00,000 each, aggregating up to Rs. 2,00,00,00,000. The NCDs will be listed on the Wholesale Debt Market (WDM) segment of BSE Limited.

Read more →📎 1 attachment
BSECompany Update▲ PositiveResults21 Jul 2026

AAVAS Financiers Ltd

Investor Release on the Financial and Operational Performance of the Company for the Quarter ended June 30, 2026

AAVAS Financiers Ltd has declared unaudited Financial Results for the quarter ending June 30, 2026, with key highlights including a 15.4% YoY growth in Assets under Management (AuM) to Rs. 239 bn, a 23% YoY growth in Net Profit to Rs. 1.71 bn, and a 22-bps YoY improvement in Net Interest Margin (NIM) to 7.70%.

Read more →📎 1 attachment
BSEBoard MeetingResults21 Jul 2026

AAVAS Financiers Ltd

Outcome of Board Meeting held on Tuesday, July 21, 2026

AAVAS Financiers Ltd has announced its unaudited financial results for the quarter ended June 30, 2026, with the Board of Directors considering and approving the results and taking note of the Limited Review Report submitted by the Joint Statutory Auditors.

Read more →📎 1 attachment
BSECompany Update22 Jun 2026

AAVAS Financiers Ltd

Clarification Letter on Market Rumour

AAVAS Financiers Ltd has issued a clarification refuting market rumours regarding alleged discrepancies in loan classifications, purported reversal of refinancing facilities by the National Housing Bank (NHB), and linked management changes. The company states these reports are misleading, malicious, speculative, and inaccurate. AAVAS confirms an ongoing routine NHB inspection, emphasizing it is standard regulatory oversight, not an adverse finding or a directive to reverse refinancing. The company reiterates its commitment to robust governance, prudent underwriting, and compliance.

Read more →📎 1 attachment
← PreviousPage 6 of 6